Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07487584Not Yet Recruiting

Study of Genetics in Childhood Obesity

Role: collaborator

NCT06017934Not ApplicableRecruiting

Promoting Increased Physical Activity in Hospitalised Older Adults

Role: collaborator

NCT06708819Not Yet Recruiting

AUGUR-AI - Indocyanine Green Fluorescence Angiography Representer

Role: collaborator

NCT05109182Not ApplicableUnknown

Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial Nephrectomy

Role: collaborator

NCT02416375Completed

Home Monitoring to Predict Exacerbation in Cystic Fibrosis

Role: collaborator

NCT04375501Completed

A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic

Role: collaborator

NCT01892163Phase 3Completed

Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone

Role: collaborator

All 7 trials loaded